Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
Oracle reported another quarter of robust cloud growth and a jaw-dropping $553 billion in remaining performance obligations, keeping the core growth story intact. The market has punished the name for heavy AI infrastructure spending and short-term cash-flow stress. This trade idea buys the dislocation: enter near $164.00, stop at $142.00, target $2…
Novo Nordisk traded near the low end of its range after a difficult 2025. The recent Hims & Hers agreement and resolution of litigation removes an uncertainty and creates a modest new distribution channel for Wegovy/Ozempic. At a market cap of roughly $172.4B and a P/E near 11, the stock offers asymmetric upside over the next 45 trading days if mom…
Kinsale's specialty underwriting economics and cash generation justify a buy here. The stock trades at a reasonable P/E with strong ROE and sizeable free cash flow, presenting a favorable risk/reward for a mid-term swing trade.
Royal Caribbean Group (RCL) is trading below momentum averages after a recent oil-driven selloff in travel names. With fuel tailwinds, record 2025 results, a 50% dividend increase and a sub-$100B enterprise value, the risk/reward favors a long trade targeting the consensus outlook near $350 over the next 6 months while using a clear stop to limit d…
Intuitive Surgical remains the leader in robotic-assisted surgery with strong recurring revenue from instruments and a growing installed base. Fundamental strength and long-term opportunity are intact, but a rich valuation (P/E ~61, market cap ~$172B) and rising competition argue for a Hold. For traders, consider a disciplined buy-on-weakness plan …
Nu Holdings ($NU) recently pulled back after a strong 2025 showing. With 45% revenue growth, reported customer counts above 100M, and a market cap near $70.2B, the company sits at an attractive risk/reward if credit performance and U.S. expansion clarity hold. This trade idea lays out a mid-term long with clear entry, target and stop.
Taiwan Semiconductor Manufacturing (TSM) dipped from recent highs as momentum cooled and short-volume ticked up. Fundamentals tied to the AI data-center buildout remain intact: TSMC controls the advanced foundry moat, reported strong 2025 revenue and EPS growth, and stands to benefit from hyperscaler capex. This trade plan buys the dip with a mid-t…
Micron has taken center stage in the AI memory race. With recent partnership news, analyst upgrades, and management signaling a robust Q2 ($18.7B revenue, $8.42 EPS), the stock looks set for another leg up into earnings. This is a momentum-driven, event-sensitive trade: enter $410.85, stop $385, target $520 with a short-term horizon (10 trading day…
United Natural Foods (UNFI) is cheap on multiple cash-flow metrics and is starting to show the early signs of margin recovery that the market may be underpricing. With free cash flow of $344M, EV/EBITDA ~10.6 and improving adjusted EPS guidance, a disciplined mid-term long where you buy into momentum and protect capital with a decisive stop makes s…
Monolithic Power Systems (MPWR) posts impressive profitability and cash generation, but the shares trade at a premium (roughly 82x EPS, ~18.6x sales) with momentum faltering. For traders willing to accept higher risk, a mid-term short (45 trading days) targeting a meaningful mean reversion offers an asymmetric trade: the fundamentals cushion downsi…
Nebius appears to have moved from concept to commercial runway after a high-profile Nvidia endorsement. That validation should open customer doors and accelerate revenue cadence, but the stock is a trade, not a buy-and-forget. We outline a mid-term swing trade with a clear entry, stop, and target, and the operational milestones that should drive th…
QuantumScape's engineering story has improved: QSE-5 samples, strategic supplier deals, and an Eagle pilot line move the company from lab promises closer to manufacturing reality. The stock, trading at $7.03 with a $4.29B market cap, still needs commercial-scale manufacturing proof. This trade idea buys the improved narrative while protecting capit…
Automatic Data Processing (ADP) is a Dividend King trading near its 52-week low with a 2.9% yield, $4.6B in free cash flow and a P/E of ~20.7. Weak near-term labor data and AI worries have driven the price lower, creating a defined-risk long trade targeting a valuation re-rate and steady cash return drivers.
Constellation Brands (STZ) looks like an actionable long trade as the company navigates a transitional 2026. The shares have pulled back from last year’s highs, valuation metrics (EV/EBITDA ~10.9x, P/E ~23.5x) are not demanding given $1.76B in free cash flow and a $26.1B market cap, and Berkshire Hathaway's interest plus recent beats create a favor…
Pagaya Technologies combines AI-driven credit underwriting with an asset-light pivot that has materially improved cash generation. At roughly 4x price-to-free-cash-flow and a market cap under $1.0B, the stock looks like a GARP (growth at a reasonable price) candidate. This trade idea outlines an entry, stop, targets, catalysts and balanced risks fo…
Hims & Hers (HIMS) just turned a legal liability into leverage: the Novo Nordisk partnership announced in early March resolved a major lawsuit and restores GLP-1 access to HIMS' telehealth channel. The stock is trading near $26.62 after a big gap; fundamentals still show strong revenue traction ($619M quarterly) and management targets $2.8B for 202…
Inspire Medical (INSP) is a leader in implantable therapy for obstructive sleep apnea. After a bruising product rollout and legal headlines, the balance sheet and cash flow remain intact, valuation is accessible and technical indicators show oversold conditions. This trade idea buys a recovery driven by improved billing, provider training completio…
Dell just reported blockbuster AI server results and laid out aggressive AI revenue targets. The stock has momentum, solid free cash flow, and valuation that still looks reasonable relative to the growth profile. This trade plan targets participation in the AI-led re-rating with defined entry, stop, and target levels and a long-term horizon of 180 …
NextEra Energy combines a regulated utility (FPL) and a massive renewable generation business (NEER). With a $190B market cap, meaningful free cash flow and a mid-20s PE, the setup is attractive for a long trade into the next 180 trading days. This idea lays out five structural positives, concrete valuation framing, catalysts, and an actionable ent…
Workday is caught between negative headlines about AI-driven SaaS disruption and a durable, cash-generative business with high switching costs. With a market cap near $37B, $2.78B in free cash flow and price-to-sales of ~3.9x, the stock is an actionable mid-term long as investors reprice durable revenue and AI investments. Entry $143.00, target $17…
Regeneron (REGN) has rallied hard from its 2025 lows and now trades at roughly $770 with a market cap near $81.3B. Fundamentals - a $42.61 EPS, healthy free cash flow and low leverage - support the premium multiple, but much of the upside is already reflected in the price. This trade idea recommends a disciplined, mid-term long on a measured pullba…
Owlet (OWLT) tumbled after a 03/09/2026 outlook that trimmed Q1 revenue expectations to $20-21M versus consensus near $26.2M. The move pushed the shares to $6.10 and left the stock deeply oversold (RSI ~21). With a market cap of roughly $168M, an enterprise value near $147M, and recent revenue momentum (Q4 revenue $26.6M, +29.6% Y/Y), this is a hig…
NextEra Energy is trading near $91.69 with a valuation that, on several metrics, sits below its own recent trading history. Solid free cash flow ($3.77B), a 2.5% dividend yield, and exposure to secular tailwinds - renewables and data-center demand - support a constructive, actionable long trade with defined risk.
Qualcomm (QCOM) is trading like a broken company after a sharp drop from the 52-week high of $205.95 to $135.20. Fundamentals tell a different story: $12.9B free cash flow, 23% ROE, and a $144B market cap. With an oversold technical backdrop, rising short interest and strong cash generation, this is a tactical long where upside from a normalization…
Apple’s free cash flow of $123.3B and a resilient hardware/services mix create a pragmatic bull case. Valuation is elevated but not extreme versus fundamentals; a tactical long with a $261 entry, $300 target and $230 stop balances upside from product catalysts and buybacks against macro and execution risks.
